S
BEAM icon

SignatureFD’s Beam Therapeutics BEAM Stock Holding History

SignatureFD’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54K Hold
74
– – ﹤0.01% 3091
2026
Q1 		$1.76K Buy
+74
New +$2.05K ﹤0.01% 3095
2025
Q3 		– Sell
-25
Closed -$425 – 3390
2025
Q2 		$425 Sell
25
-370
-94% -$6.44K ﹤0.01% 3125
2025
Q1 		$7.71K Sell
395
-32
-7% -$838 ﹤0.01% 2454
2024
Q4 		$10.6K Sell
427
-147
-26% -$3.75K ﹤0.01% 2345
2024
Q3 		$14.1K Sell
574
-148
-20% -$3.82K ﹤0.01% 2208
2024
Q2 		$16.9K Sell
722
-346
-32% -$8.5K ﹤0.01% 2048
2024
Q1 		$35.3K Buy
1,068
+47
+5% +$1.46K ﹤0.01% 1723
2023
Q4 		$27.8K Sell
1,021
-1,661
-62% -$41.3K ﹤0.01% 1760
2023
Q3 		$64.5K Buy
2,682
+2,625
+4,605% +$70.4K ﹤0.01% 1267
2023
Q2 		$1.82K Buy
57
+50
+714% +$1.62K ﹤0.01% 2835
2023
Q1 		$214 Sell
7
-143
-95% -$5.64K ﹤0.01% 3186
2022
Q4 		$5.87K Buy
150
+20
+15% +$896 ﹤0.01% 2395
2022
Q3 		$6K Hold
130
– – ﹤0.01% 2315
2022
Q2 		$5K Sell
130
-11
-8% -$437 ﹤0.01% 2426
2022
Q1 		$8K Buy
141
+65
+86% +$4.26K ﹤0.01% 2243
2021
Q4 		$6K Sell
76
-104
-58% -$8.9K ﹤0.01% 2318
2021
Q3 		$16K Buy
180
+52
+41% +$5.22K ﹤0.01% 1848
2021
Q2 		$16K Buy
+128
New +$10.2K ﹤0.01% 1796

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

SignatureFD's BEAM Position: Q2 2026 in Review

SignatureFD held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 74 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #3091.

SignatureFD first reported a position in BEAM in Q2 2021 and has held it in 19 quarters since. The position peaked at $64.5K in Q3 2023. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • SignatureFD held 74 shares of Beam Therapeutics worth $2.54K as of Q2 2026.
  • SignatureFD left its Beam Therapeutics share count unchanged in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3091 holding.
  • SignatureFD first reported a position in Beam Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • SignatureFD's Beam Therapeutics position peaked at $64.5K in Q3 2023.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.